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Miiller  (1888)  first  described the presence in  human  purulent  sputum  of 
protease  active  at  neutral  pH.  Achalme (1899) was  the  first  to  find  this 
enzyme in human pus.  Jobling and Strouse (1912) showed that extracts of 
human  pus also contain peptidase active at neutral pH.  Opie (1905,  1922) 
showed that polymorphonuclear leucocytes are the chief source of leucoprotease 
(named by him) and was the first to emphasize the physiological significance of 
this protease and  of its inhibition  by serum.  He demonstrated  that  leuco- 
protease plays a  major rSle  in  the resolution of in~ammatory  exudates,  and 
that  serum  (in  sufficient  concentration)  can retard  this  resolution by virtue 
of its inhibitory power.  More recent workers (Hoimes eta/., 1935) have applied 
these principles to the study of suppurative arthritis and have shown that the 
presence of antiproteolytic substances in synovlal exudates is of  great  impor- 
tance in the prevention of damage to joints by protease liberated from the poly- 
morphonuclear leucocytes of these exudates.  However, the general problem 
of the relation of leucoprotease and serum antiprotease to the resolution and 
absorption  of ioflammatory exudates and  absorbable foreign bodies has  not 
been intensively studied since  the work of Opie early in the century.  It is 
hoped that  the experiments described in the preceding paper on the control 
of leucoprotease and serum antiprotease will facilitate such a study by enabling 
better control of the activity of these important substances than has hitherto 
been possible. 
The  experiments  of Menkin  (1938) and others indicate that the increased 
capillary permeability and leucocyte infiltration characteristic of inflammation 
are due to a  polypeptide formed by proteolysis at  the site of inflammation. 
Evidence has also been presented  (Rocha e Silva,  1941, 1942) that local pro- 
teolysls in  the  tissues  liberates histamine,  which  is  thought  by some to be 
important  in  inflammation  and  anaphylaxis.  The  ability  to  control  the 
activity  of leucoprotease and  of serum  antiprotease  may perhaps  faciliate 
further investigation of these phenomena. 
* Emanud Libman Fellow in Medicine at the time of completion of this work in 
June, 1943. 
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Other physiological and pathological processes in which the abifity to control 
the activity of leucoprotease (or other proteases) and serum antiprotease may 
prove to be of value include: 
(1)  The neutralization of the destructive protease liberated in acute pan- 
creatitis and from duodenal fistulae. 
(2)  The experimental production (Rich and Duff, 1937) of hyaline arterio- 
sclerosis and arteriolonecrosis by subcutaneous injection of proteolytic enzymes. 
(The local necrosis produced by trypsin has been shown to be inversely propor- 
tional to the antiproteolytic activity of the serum (Grob, 1943).) 
(3)  The coagulation of the blood.  Eagle and Harris  (1936-37)  have pre- 
sented evidence that, in the course of physiological coagulation, calcium plus 
thromboplastin constitutes a proteolytic enzyme system (analogous to trypsin) 
which is believed to be responsible for the transformation of prothrombin to 
thrombin, itself thought to be a proteolytic enzyme that accelerates the trans- 
formation of fibrinogen to fibrin.  More recently evidence has been presented 
(Grob, 1943) that purified serum antitrypsin and pancreatic trypsin inhibitor 
inhibit the coagulation of plasma in vitro. 
(4)  The possibility of prolonging insulin action by retarding the breakdown 
of insulin by serum protease (and other proteases?). 
(5)  Possibly  the  release  of  thyroglobulin  by  the  thyroid  gland.  Para- 
aminobenzoic acid,  sulfonamides, and  thiourea,  which have  been  shown  to 
inhibit leucoprotease, are known (Mackenzie and Mackenzie, 1943, Astwood 
et  al.,  1943) to  inhibit the activity of the  thyroid gland.  Dziemian  (1943) 
was able to correlate the activity of the thyroid gland of rats with the pro- 
teolytic (catheptic) activity of thyroid extracts.  He found that sulfaguanidine 
decreased both activities, and presented evidence in support of the suggestion 
of Gersh and Caspersson (1940) that a proteolytie enzyme in the thyroid hy- 
drolyzes thyroglobulin into peptones or polypeptides which are small enough 
to pass across the cell membranes and are then reconstituted by enzyme action 
into a larger molecule. 
(6)  Bacterial growth and sulfonamide action (discussed below). 
In a previous paper (Grob, 1943) evidence was presented that: 
(1)  Heating diluted serum at 80°C. for 10 minutes makes it a better medium for 
bacterial growth.  This is believed to have been at least partly due to destruction of 
the serum antiprotease by heat.  (2)  Growth is accelerated and proceeds further in 
the presence of trypsin.  (3)  Growth is somewhat retarded in the presence of pan- 
creatic trypsin inhibitor.  (4)  The bacteriostatic action of sulfathiazole in serum is 
reduced by heating the serum at 80°C. for 10 minutes and much more markedly by 
adding trypsin.  It is greater in serum and albumin than in peptone and meat infusion. 
These findings were taken to indicate that the products of tryptic digestion promote 
bacterial growth, and directly and indirectly inhibit the bacteriostatic action of sulfa- 
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in the body will be more rapid, and the inhibition of sulfathiazole will be greater: (a) 
when considerable  leucoprotease (and peptidase?) is present; (b) when the organism 
itself produces active protease (and peptidase?); (c) when the inflammatory exudate 
is small and poor in antiprotease; (d) when the source of anfiprotease (the blood) is 
poor in this constituent; and  (e) when the medium is rich in non-protein nitrogen 
(especially para-aminobenzoic acid?). 
These conclusions would not be valid if leucoprotease could not be shown to 
have the same effect on bacterial growth and sulfonamide action as was shown 
for crude trypsin.  To  investigate this the growth of Escherichia coli, Proteus 
vulgaris, Staphylococcus aureus, Streptococcus pyogenes, and Clostridium welckii 
was followed in the following media: 
(1)  10 per cent human serum (serum diluted with isotonic phosphate buffer and 
heated at 56°C. for 30 minutes to destroy complement, so as to eliminate the action 
of normal bactericidal antibodies). 
(2)  1 heated at 80°C. for 10 minutes to destroy antiproteolytic activity. 
(3)  1 +  sulfathiazole (0.1 mg./cc.). 
(4)  2  +  sulfathiazole (0.1 reg./co.). 
Growth was followed  in  these media in  the absence of added enzyme, and in the 
presence of crude trypsin (1.0 mg./cc.), crystalline trypsin (0.25 mg./cc.), and leuco- 
protease (cat, lyo-, equivalent to 0.2  mg./ce, crude trypsin).  Bacterial growth was 
determined by measuring the turbidity of bacterial suspensions  after 24 hours' in- 
cubation at 37°C.  by means of a  photoelectric nephelometer.  The opacity of the 
suspension  is represented as the number of 24 hour old organisms (determined by 
direct count) which, when suspended in "the same medium, allowed the same amount 
of light to be transmitted.  A small correction was made for changes in the opacity 
of the  medium resulting from incubation alone  (especially  for heated  serum  plus 
enzyme), by incubating  under  toluene  control  tubes  of similar composition.  The 
error produced by the digestion  of dead bacteria by protease (resulting in some den 
crease  in turbidity)  was not corrected for, but several pour plate counts of viable 
bacteria  indicated  that  this  error  did  not  affect the  conclusions  drawn  from  the 
experiment. 
The initial concentration of bacteria in each case was approximately 5 million/cc. 
Except for Clostridium welchii (which was obtained from thioglycoflate medium) the 
organisms were obtained from 48 hour old agar slant cultures, and all were washed 
repeatedly in saline before addition to the test media.  Clostridium welchii was grown 
under vaseline to insure anaerobic conditions. 
Examination of the data  (Table I) reveals that: 
(a)  Growth proceeded further in serum that had been heated at 80°C.  for 
10 minutes to destroy serum antiprotease than in serum that had merely been 
heated  sufficiently  to  destroy  complement.  (However,  the  destruction  of 
serum antiprotease cannot  be said  to  be alone responsible for the  increased 
growth, since denaturation of proteins by heat alters the rate at which they are 
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(b)  Growth  proceeded  further  in media  to which  crude trypsin,  crystalline 
trypsin, or leucoprotease had been added. 
(c)  The  bacteriostatic  action  of  sulfathiazole  was:  (1)  somewhat  reduced 
by  destruction  of  the  antiproteolytic  activity  of  the  serum  (by heat,  which 
altered  the  serum  in  other  ways too);  (2)  reduced  by the  presence  of crude 
trypsin,  leucoprotease,  or  (to  a  lesser  extent)  crystalline  trypsin;  (3)  not 
TABLE I 
Tke Influence of Proteolyt~c Enzymes and Serum Antiprotcase  on Bacterial Growth and Sulfon- 
amide Action 
Organism .......... 
Antiproteolytic  activity  of  the 
serum ..... 
Enzyme  Sulfathiazole 
None 
Crude trypsin 
Crystalline 
trypsin 
Leucoprotease 
Boiled leuco- 
protease 
0 
0.1  mg./cc. 
0 
0.1  mg./cc. 
0 
0.1  reg./co. 
0 
0.1  mg./cc. 
0.1  mg./cc. 
Esd~rickia  Proteus  Stcphyloco¢-  Streptococcus 
coti,  vulgaris,  cus aureus,  pyogencs, 
millions/ee,  miUions/cc, millions/ce,  millions/ce. 
after 24 hrs.  aft~ 24 hrs.  after 24 hrs.  after 24 hrs. 
! 
• Intact  0 
,i 
115380 
70  125 
! 
165  580 
175264 
125520 
125  185 
260  580 
95  185 
125 
] 
Intact  0  Intact 
125  155  105 
25  55  45 
i 
135185  125 
25  I 165  85 
i 
145]  285  105 
45  40  65 
i 
145  30O  105 
75  200  65 
55 
Clostridium 
welchli, 
millions/cc. 
after 24 hrs. 
0  Intact  0  Intact 
260  90  145  180 
145  45  70  80 
385  165  165  305 
165  65  75  300 
265  180  325  265 
140  40  70  165 
445  180  350  225 
345  85  70  185 
150  90 
0 
280 
85 
320 
265 
270 
200 
245 
225 
100 
influenced  by boiled  leucoprotease,  which  also  had  no  appreciable  effect  on 
bacterial  growth. 
These results  indicate  that  the  products  of protein hydrolysis by leucopro- 
tease accelerate bacterial growth and inhibit sulfonamide action,  in a  manner 
similar to that previously described for the products of protein hydrolysis by 
crude  trypsin.  They  also  suggest  that  while  the  products  of hydrolysis  by 
crystalline  trypsin  accelerate  bacterial  growth  to  about  the  same  extent  as 
those  of crude  trypsin,  the  former  (higher)  degradation  products  are  not  as 
effective in the inhibition  of sulfonamide action. 
Evidence was previously presented  (Grob, 1943)  that trypsin inhibitor pos- 
sesses no bactericidal  activity,  and  trypsin  no  antibactericidal  activity.  Al- 
though  corresponding  experiments were not performed for leucoprotease,  it is 
probable  that  this  protease  would  also  be found  to have  no  bactericidal  or DAVID  GROB  253 
antibactericidal  activity.  However,  the  polymorphonuclear  leucocytes  of 
many animals do contain a  bactericidal substance  ("leukin"),  which may be 
identical with lysozyme (Barnes, 1940)  and which will be present at the site of 
Lnflnmmation and in extracts of the polymorphs. 
The inhibitory effect of peptone and of various bacterial extracts on sulfonamides 
has been the  subject of intensive study  (Lockwood,  1938; McIntosh and Whitby, 
1939; Stamp, 1939).  Woods (1940) has advanced evidence that this inhibitory effect 
is due to the presence of para-aminobenzoic acid, and has attributed to the presence 
of para-aminobenzoic acid preformed in the medium the observed (Lockwood e~ a/., 
1937) difficulty  of inhibiting bacteria by the use of sulfonamide in peptone and in 
lesions  characterized by considerable  tissue destruction.  MacLeod (1940) has cor- 
related sulfonamide inhibition with the degree of tissue autolysis (which, he believes, 
liberates  para-aminobenzoic  acid  from  a  preexisting  conjugated  form).  Others 
(Lockwood and Lynch, 1940) have pointed out that organisms known to be susceptible 
to sulfonamides are in general not actively proteolytic, and it is believed (MacLeod, 
1940) that they are probably not capable of producing much para-aminobenzoic acid. 
Evidence has been presented that para-aminobenzoic acid also inhibits the "bac- 
teriostatic"  action  of  sulfonamides  (Fitzgerald  and  Feinstone,  1943) and  promin 
(Steenken and Heise, 1943) on tubercle bacilli, and of sulfonamides on the Plasmodium 
of bird malaria and on the virus of lymphogranuloma venereum (Maier and Riley, 
1942). 
Green and Bielschowsky  (1942) have emphasized that the antisulfonamide activity 
of bacterial and yeast extracts is exerted directly by para-aminobenzoic acid and simi- 
lar sulfonamide inhibitors,  and  indirectly by substances which  stimulate bacterial 
growth,  even  in  an  optimal  nutrient  medium.  (Para-aminobenzoic  acid  itself 
stimulates the growth of very few organisms (Rubbo and Gillespie,  1940; Sevag and 
Shelburne,  1942; Rantz, 1942).)  These latter substances which stimulate growth will 
also exert their indirect inhibiting  effect  against  other  bacteriostatic  agents  than 
the  sulfonamides;  e.g., against penicillin  (Green and Bielschowsky,  1942). 
Not only the properties of the medium, but also the properties of the bacteria in- 
fluence sulfonamide action.  It is believed (Woods,  1940; Green and Bielschowsky, 
1942) that the degree of sensitivity of bacteria to sulfonamides is determined by the 
extent  to  which  para-aminobenzoic acid  and  related  "essential  metabolites" are 
necessary to the life cycle of the bacteria, and by the rate at which para-aminobenzoic 
acid is synthesized and released  into the surrounding medium.  Many investigators 
have attempted to discover a chemotherapeutic agent which would react with para- 
aminobenzoic acid, and/or reduce the rate of synthesis of para-aminobenzoic acid by 
bacteria.  It is thought that azochloramide and related halogen compounds (Schmelkes 
and Wyss, 1942), and perhaps urea (Tenenberg et al., 1942) are capable of neutralizing 
the action of para-aminobenzoic acid and may thereby prove to be useful as potentia- 
tors of the sulfonamides. 
The experiments on leucoprotease described above indicate  that  leuCopro- 
tease activity, such as occurs at any site of bacterial growth with its concomitant 
inflammation, results in the production of protein degradation products which 254  PROTEOLYTICENZYMt~S. 
stimulate  bacterial  growth,  and  directly and  indirectly  inhibit  sulfonamide 
action.  (A third way in which leucoprotease activity increases bacterial growth 
in the presence of sulfonamides is by causing  an accumulation of acid products 
of hydrolysis, which decrease sulfonamide action since sulfonamides have been 
shown (Schrnelkes et al.,  1942) to be less active at decreased pH.  Of course, 
when the pH falls too low, as in a poorly buffered medium, bacterial growth will 
be retarded.) 
It is to be expected that substances which inhibit the activity of leucoprotease 
e.g.,  serum,  reducing  agents, heavy metals, etc.) will inhibit the production of 
protein degradation products at the site of bacterial growth and inflammation, 
and will thereby act to prevent the acceleration  of bacterial growth, and the 
inhibition  of sulfonamide action,  that  these products cause.  It is suggested 
that the search  for sulfonamide potentlators be directed not only toward the 
discovery of agents which will destroy sulfonamide  inhibitors once formed, but 
also toward the utilization of substances which will prevent the formation of 
these inhibitors  (and  of the degradation  products which stimulate  bacterial 
growth)  by retarding  the action  of leucoprotease  (and  perhaps  of bacterial 
proteases as well).  This would seem to  be especially desirable in  purulent 
lesions, where the sulfonamides have proved least efficacious.  With respect to 
the use of bacteriostatic  agents  which are not inhibited  in purulent  lesions 
(e.g.  penicillin)  it would still seem desirable to control the production by pro- 
teolysis of degradation products which have been shown to directly stimulate 
bacterial growth.  It is hoped that the data presented in the preceding paper 
on the control of the activity of leucoprotease and serum antiprotease may prove 
applicable in these respects. 
SUMMARY 
It has been suggested that the ability to control the activity of leucoprotease 
and  serum  antiprotease  may prove useful in  the  further  study and  under- 
standing of such phenomena as:  (1) inflammation; (2)  the resolution of inflam- 
matory exudates and the absorption of absorbable foreign  bodies; (3) the pro- 
tection of joint and other structures from the proteolytic action of leucoprotease; 
(4) the neutralization of the destructive protease liberated in acute pancreatitis 
and from duodenal fistulae; (5)  experimental  arteriosclerosis  and  arteriolone- 
crosis;  (6)  the coagulation of the blood; (7)  the possibility of prolonging the 
action of insulin;  (8)  the release  of thyroglobulin by the thyroid gland;  (9) 
bacterial growth and sulfonamide action. 
In  this last respect evidence has been presented that  the products of the 
hydrolysis of protein by leucoprotease stimulate bacterial growth and  directly 
and indirectly inhibit sulfonamide action,  and  the hope  has  been  expressed 
that  the ability to control leucoprotease action may contribute to the  more 
successful use of chemotherapeutic agents in purulent lesions. DAVID GROB  255 
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